TCL Archive Advisors approve NCI’s revised plan for $104-million proteomics research program. July 8, 2005
TCL Archive FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions. June 2, 2006
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says May 31, 1991
